Pharmaceutical company Cipla has announced its march ended quarter and FY 17 results on 25th May 2017.
The results does not seem that much impressive numbers
The results does not seem that much impressive numbers
- Net loss of 61.79 crore is reported against 92.83 crore in same quarter of last year.
- Total income from operations is declined 2695.17 crore against 2782.78 in same quarter of last year.
- The board of the company approved dividend of Rs 2 per equity share of face value of Rs 2 per share in a BSE filing.
- Cipla’s consolidated total revenue increased by 6.84 per cent to Rs 3,604.79 crore in the quarter under review, as against Rs 3,373.91 crore in the corresponding quarter.
- Share price is delcined by 3% nearly due to this poor perfomance.
- The stock is open at 483 an trading at 491.30 at 11 o'clock.
No comments:
Post a Comment